Search research articles
Contact Us
Filters
Showing results (351-360 of 500) with videos related to
Page
of 50
Sort By:
Neuron
|
July 13, 1999
Role of alpha9 nicotinic ACh receptor subunits in the development and function of cochlear efferent innervation
D E Vetter, M C Liberman, J Mann, et al.
Parasite Immunology
|
February 1, 1994
Theileria annulata sporozoite surface antigen (SPAG-1) contains neutralizing determinants in the C terminus
N Boulter, P A Knight, P D Hunt, et al.
Neurosurgery
|
March 22, 2022
Comparative Therapeutic Effectiveness of Anticoagulation and Conservative Management in Traumatic Cerebral Venous Sinus Thrombosis
Kevin T Kim, Aaron P Wessell, Jeffrey Oliver, et al.
Nature Communications
|
October 17, 2019
Embryonic mesothelial-derived hepatic lineage of quiescent and heterogenous scar-orchestrating cells defined but suppressed by WT1
Timothy James Kendall, Catherine Mary Duff, Luke Boulter, et al.
Experimental Parasitology
|
August 26, 1998
Identification of a Theileria annulata antigen expressed in multiple stages of the parasite life cycle
P A Knight, S W Williamson, C G Brown, et al.
Plos Pathogens
|
November 22, 2011
The role of the P2X₇ receptor in infectious diseases
Catherine M Miller, Nicola R Boulter, Stephen J Fuller, et al.
The Journal of Biological Chemistry
|
June 2, 2007
Different T cell receptor affinity thresholds and CD8 coreceptor dependence govern cytotoxic T lymphocyte activation and tetramer binding properties
Bruno Laugel, Hugo A van den Berg, Emma Gostick, et al.
Cancer Research
|
October 1, 2014
CD98hc (SLC3A2) loss protects against ras-driven tumorigenesis by modulating integrin-mediated mechanotransduction
Soline Estrach, Sin-Ae Lee, Etienne Boulter, et al.
Topics in Magnetic Resonance Imaging : TMRI
|
June 9, 2020
Practical Considerations for Radiologists in Implementing a Patient-friendly MRI Experience
Murat Alp Oztek, Christina L Brunnquell, Michael N Hoff, et al.
Cancer Chemotherapy and Pharmacology
|
May 18, 2023
Phase I trial of intravenous fenretinide (4-HPR) plus safingol in advanced malignancies
Alexis C Boulter, Barry J Maurer, Meredith Pogue, et al.
Page
of 50
Search research articles
Search
Showing results (351-360 of 500) with videos related to
Sort By:
Page
of 50
Neuron
|
July 13, 1999
Role of alpha9 nicotinic ACh receptor subunits in the development and function of cochlear efferent innervation
D E Vetter, M C Liberman, J Mann, et al.
Parasite Immunology
|
February 1, 1994
Theileria annulata sporozoite surface antigen (SPAG-1) contains neutralizing determinants in the C terminus
N Boulter, P A Knight, P D Hunt, et al.
Neurosurgery
|
March 22, 2022
Comparative Therapeutic Effectiveness of Anticoagulation and Conservative Management in Traumatic Cerebral Venous Sinus Thrombosis
Kevin T Kim, Aaron P Wessell, Jeffrey Oliver, et al.
Nature Communications
|
October 17, 2019
Embryonic mesothelial-derived hepatic lineage of quiescent and heterogenous scar-orchestrating cells defined but suppressed by WT1
Timothy James Kendall, Catherine Mary Duff, Luke Boulter, et al.
Experimental Parasitology
|
August 26, 1998
Identification of a Theileria annulata antigen expressed in multiple stages of the parasite life cycle
P A Knight, S W Williamson, C G Brown, et al.
Plos Pathogens
|
November 22, 2011
The role of the P2X₇ receptor in infectious diseases
Catherine M Miller, Nicola R Boulter, Stephen J Fuller, et al.
The Journal of Biological Chemistry
|
June 2, 2007
Different T cell receptor affinity thresholds and CD8 coreceptor dependence govern cytotoxic T lymphocyte activation and tetramer binding properties
Bruno Laugel, Hugo A van den Berg, Emma Gostick, et al.
Cancer Research
|
October 1, 2014
CD98hc (SLC3A2) loss protects against ras-driven tumorigenesis by modulating integrin-mediated mechanotransduction
Soline Estrach, Sin-Ae Lee, Etienne Boulter, et al.
Topics in Magnetic Resonance Imaging : TMRI
|
June 9, 2020
Practical Considerations for Radiologists in Implementing a Patient-friendly MRI Experience
Murat Alp Oztek, Christina L Brunnquell, Michael N Hoff, et al.
Cancer Chemotherapy and Pharmacology
|
May 18, 2023
Phase I trial of intravenous fenretinide (4-HPR) plus safingol in advanced malignancies
Alexis C Boulter, Barry J Maurer, Meredith Pogue, et al.
Page
of 50